Arnaud Bruyère

742 total citations
35 papers, 595 citations indexed

About

Arnaud Bruyère is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Arnaud Bruyère has authored 35 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 16 papers in Pediatrics, Perinatology and Child Health and 11 papers in Pharmacology. Recurrent topics in Arnaud Bruyère's work include Drug Transport and Resistance Mechanisms (22 papers), Pharmacological Effects and Toxicity Studies (16 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Arnaud Bruyère is often cited by papers focused on Drug Transport and Resistance Mechanisms (22 papers), Pharmacological Effects and Toxicity Studies (16 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Arnaud Bruyère collaborates with scholars based in France, Switzerland and Germany. Arnaud Bruyère's co-authors include Olivier Fardel, Marc Le Vée, Yannick Parmentier, Elodie Jouan, Claire Denizot, Sophie Potin, Sophie Rose, Xavier Declèves, Sophie Langouët and Vincent Legagneux and has published in prestigious journals such as PLoS ONE, Scientific Reports and Environmental Pollution.

In The Last Decade

Arnaud Bruyère

35 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arnaud Bruyère France 15 267 148 146 99 62 35 595
Claire Denizot France 13 309 1.2× 110 0.7× 159 1.1× 151 1.5× 22 0.4× 27 563
Brigitte Gerin Belgium 7 132 0.5× 215 1.5× 127 0.9× 226 2.3× 38 0.6× 11 761
Helen Hammer Germany 11 147 0.6× 162 1.1× 60 0.4× 154 1.6× 25 0.4× 30 469
Tomáš Smutný Czechia 17 162 0.6× 219 1.5× 50 0.3× 224 2.3× 20 0.3× 33 710
Georg F. Kahl Germany 16 373 1.4× 211 1.4× 91 0.6× 269 2.7× 41 0.7× 34 820
Xiaobo Yang China 18 262 1.0× 235 1.6× 61 0.4× 310 3.1× 49 0.8× 31 836
Nathalie Maubon France 8 245 0.9× 55 0.4× 85 0.6× 112 1.1× 13 0.2× 10 478
Jenni Küblbeck Finland 16 110 0.4× 225 1.5× 24 0.2× 292 2.9× 52 0.8× 36 770
Bettina Ebert Germany 12 272 1.0× 159 1.1× 87 0.6× 345 3.5× 23 0.4× 17 803
Juan Pablo Rigalli Argentina 18 390 1.5× 136 0.9× 99 0.7× 369 3.7× 18 0.3× 52 891

Countries citing papers authored by Arnaud Bruyère

Since Specialization
Citations

This map shows the geographic impact of Arnaud Bruyère's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnaud Bruyère with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnaud Bruyère more than expected).

Fields of papers citing papers by Arnaud Bruyère

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnaud Bruyère. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnaud Bruyère. The network helps show where Arnaud Bruyère may publish in the future.

Co-authorship network of co-authors of Arnaud Bruyère

This figure shows the co-authorship network connecting the top 25 collaborators of Arnaud Bruyère. A scholar is included among the top collaborators of Arnaud Bruyère based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnaud Bruyère. Arnaud Bruyère is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vée, Marc Le, et al.. (2025). Repression of bile salt efflux pump expression by tri-ortho-cresyl phosphate in cultured human hepatic cells. Toxicology in Vitro. 105. 106021–106021. 1 indexed citations
2.
Vée, Marc Le, et al.. (2024). Lack of effects of polystyrene micro- and nanoplastics on activity and expression of human drug transporters. Environmental Toxicology and Pharmacology. 111. 104563–104563. 3 indexed citations
3.
Vée, Marc Le, et al.. (2024). Inhibition of human drug transporter activities by succinate dehydrogenase inhibitors. Chemosphere. 358. 142122–142122. 1 indexed citations
4.
Rose, Sophie, Frédéric Ezan, Ulrich Jarry, et al.. (2022). In vitro long term differentiation and functionality of three-dimensional bioprinted primary human hepatocytes: application for in vivo engraftment. Biofabrication. 14(3). 35021–35021. 18 indexed citations
5.
Fardel, Olivier, et al.. (2022). Interactions of organophosphorus pesticides with ATP-binding cassette (ABC) drug transporters. Xenobiotica. 52(6). 644–652. 1 indexed citations
6.
Vée, Marc Le, et al.. (2021). Substrate-Dependent Trans-Stimulation of Organic Cation Transporter 2 Activity. International Journal of Molecular Sciences. 22(23). 12926–12926. 5 indexed citations
7.
Moreau, A, Arnaud Bruyère, Elodie Jouan, et al.. (2021). Inhibition of organic cation transporter 3 activity by tyrosine kinase inhibitors. Fundamental and Clinical Pharmacology. 35(5). 919–929. 8 indexed citations
8.
Rose, Sophie, Frédéric Ezan, Arnaud Bruyère, et al.. (2021). Generation of proliferating human adult hepatocytes using optimized 3D culture conditions. Scientific Reports. 11(1). 515–515. 39 indexed citations
9.
Bruyère, Arnaud, Alain Lescoat, Elodie Jouan, et al.. (2020). Interactions of janus kinase inhibitors with drug transporters and consequences for pharmacokinetics and toxicity. Expert Opinion on Drug Metabolism & Toxicology. 17(3). 259–271. 21 indexed citations
10.
Vée, Marc Le, Astrid Bacle, Arnaud Bruyère, & Olivier Fardel. (2019). Neonicotinoid pesticides poorly interact with human drug transporters. Journal of Biochemical and Molecular Toxicology. 33(10). e22379–e22379. 9 indexed citations
11.
Bruyère, Arnaud, et al.. (2019). Implication of human drug transporters to toxicokinetics and toxicity of pesticides. Pest Management Science. 76(1). 18–25. 23 indexed citations
12.
Mayati, Abdullah, A Moreau, Marc Le Vée, et al.. (2018). Functional polarization of human hepatoma HepaRG cells in response to forskolin. Scientific Reports. 8(1). 16115–16115. 22 indexed citations
13.
Bruyère, Arnaud, et al.. (2017). The JAK1/2 Inhibitor Ruxolitinib Reverses Interleukin-6-Mediated Suppression of Drug-Detoxifying Proteins in Cultured Human Hepatocytes. Drug Metabolism and Disposition. 46(2). 131–140. 32 indexed citations
14.
Bruyère, Arnaud, Marc Le Vée, Bruno Stieger, et al.. (2017). Inhibition of Human Drug Transporter Activities by the Pyrethroid Pesticides Allethrin and Tetramethrin. PLoS ONE. 12(1). e0169480–e0169480. 40 indexed citations
15.
Bruyère, Arnaud, et al.. (2017). In Silico Prediction for Intestinal Absorption and Brain Penetration of Chemical Pesticides in Humans. International Journal of Environmental Research and Public Health. 14(7). 708–708. 31 indexed citations
16.
Bruyère, Arnaud, et al.. (2016). PBPK model of methotrexate in cerebrospinal fluid ventricles using a combined microdialysis and MRI acquisition. European Journal of Pharmaceutics and Biopharmaceutics. 104. 117–130. 5 indexed citations
17.
Mayati, Abdullah, Arnaud Bruyère, A Moreau, et al.. (2015). Protein Kinase C-Independent Inhibition of Organic Cation Transporter 1 Activity by the Bisindolylmaleimide Ro 31-8220. PLoS ONE. 10(12). e0144667–e0144667. 12 indexed citations
18.
Jossé, Rozenn, et al.. (2014). Interactions of Endosulfan and Methoxychlor Involving CYP3A4 and CYP2B6 in Human HepaRG Cells. Drug Metabolism and Disposition. 42(8). 1235–1240. 21 indexed citations
19.
20.
Alberto, P., Johannes Winkelmann, Arnaud Bruyère, et al.. (1989). Phase I study of oral doxifluridine using two schedules. European Journal of Cancer and Clinical Oncology. 25(5). 905–908. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claire Denizot Breakdown of academic impact, for papers by Brigitte Gerin Breakdown of academic impact, for papers by Helen Hammer Breakdown of academic impact, for papers by Tomáš Smutný Breakdown of academic impact, for papers by Georg F. Kahl Breakdown of academic impact, for papers by Xiaobo Yang Breakdown of academic impact, for papers by Nathalie Maubon Breakdown of academic impact, for papers by Jenni Küblbeck Breakdown of academic impact, for papers by Bettina Ebert Breakdown of academic impact, for papers by Juan Pablo Rigalli
Rankless by CCL
2026